semaglutide pills reviews Type 2 diabetes: New Ozempic pill now available in the U.S FuturHealth Under Review: Best GLP-1
Description
TRIUMPH-4 represents Eli Lilly's first successful Phase 3 trial for Retatrutide, moving beyond the promising Phase 2 results from 2023 that showed 24% weight loss
If tirzepatide is clinically appropriate, we prescribe it
Importantly, it should be noted that diet and exercise are still critical recommendations for long-term weight-management - even for those taking GLP-1 drugs
September 1, 2025
